. Author manuscript; available in PMC: 2022 Jun 1.

Published in final edited form as: Obesity (Silver Spring). 2021 Apr 24;29(6):1014–1021. doi: 10.1002/oby.23149

Table 1.

Participant demographics, VLDL-TG and plasma palmitate kinetic information.

	N = 25
Sex (Female/Male)	(15/10)
Age (years)	39 ± 9
BMI (kg/m²)	47.8 ± 8.2
Body fat (%)	51 ± 5
Visceral fat area (cm²)	227 ± 84
Visceral fat (kg)	7.7 ± 3.4
Upper body subcutaneous fat (kg)	37.5 ± 10.9
Fasting plasma insulin (mcIU/mL)^A	6.7 ± 4.8
Fasting plasma glucose (mmol/L)^A	5.8 ± 0.8
HOMA-IR^A	3.11 ± 1.45
Fasting plasma HDL-cholesterol (mg/dL)^A	37 ± 8
Fasting plasma triglycerides (mg/dL)^A	158 ± 41
Fasting plasma total cholesterol (mg/dL)^A	135 ± 55
Resting energy expenditure (Kcal/d)^A	2316 ± 438
VLDL-TG concentration (μmol/L)^A	865 ± 395
VLDL oxidation (%)^A	29 ± 8
Palmitate concentration (μmol/L)^B	209 ± 53
Palmitate flux (μmol/min)^B	168 ± 47

Data are represented as mean ± SD. BMI, body mass index; VLDL, very-low density lipoprotein; TG, triglycerides.

data from the VLDL infusion study day

data from the day of surgery.